In addition, a body of studies has shown that eNOS deficiency “inhibits” VEGF-mediated angiogenesis in various conditions including cancer [67, 75, 76], indicating that eNOS is a critical downstream mediator of VEGF angiogenesis. Here, NOS3 is linked to cancer.